| 臺大學術典藏 |
2018-09-10T18:07:16Z |
Potential roles of vitamin E in age-related changes in skeletal muscle health
|
Chung, E. and Mo, H. and Wang, S. and Zu, Y. and Elfakhani, M. and Rios, S.R. and Chyu, M.-C. and Yang, R.-S. and Shen, C.-L.; RONG-SEN YANG |
| 臺大學術典藏 |
2021-05-31T02:56:54Z |
Potential roles of vitamin E in age-related changes in skeletal muscle health
|
Chung E.; Mo H.; Wang S.; Zu Y.; Elfakhani M.; Rios S.R.; Chyu M.-C.; RONG-SEN YANG; Shen C.-L. |
| 國立臺灣科技大學 |
2009-11-02 |
Potential Savings for Induction Motor Drive Systems for Heating Ventilation and Air Conditioning Applications
|
Johan Astrom;Torbj?rn Thiringer |
| 建國科技大學 |
2014-05 |
Potential Second Language Factors in Cross-cultural Computer-mediated Communication
|
吳品湘, ;Wu, Pin-hsiang |
| 臺大學術典藏 |
2021-01-15T02:46:19Z |
Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems
|
SONG-CHOU HSIEH; Tsai C.-Y.; Yu C.-L. |
| 臺大學術典藏 |
2021-01-27T01:37:59Z |
Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems
|
Hsieh S.-C.; Tsai C.-Y.; CHIA-LI YU |
| 國立成功大學 |
2014-07 |
Potential Significance of EMP3 in Patients with Upper Urinary Tract Urothelial Carcinoma: Crosstalk with ErbB2-PI3K-Akt Pathway
|
Wang, Yi-Wen; Li, Wei-Ming; Wu, Wen-Jeng; Chai, Chee-Yin; Liu, Hsiao-Sheng; Lai, Ming-Derg; Chow, Nan-Haw |
| 亞洲大學 |
2014-07 |
Potential Smoothened Inhibitor from Traditional Chinese Medicine against the Disease of Diabetes, Obesity, and Cancer
|
Kuan-Chung Chen;Mao-Feng Sun;Hsin-Yi Chen;Cheng-Chun Lee;Calvin Yu-Chian Chen |
| 亞洲大學 |
2014-07 |
Potential Smoothened Inhibitor from Traditional Chinese Medicine against the Disease of Diabetes, Obesity, and Cancer
|
Kuan-Chung, C;Chen, Kuan-Chung;Sun, Mao-Feng;Sun, Mao-Feng;Chen, Hsin-Yi;Chen, Hsin-Yi;Cheng-Chun, L;Lee, Cheng-Chun;陳語謙* |
| 臺大學術典藏 |
2020-02-19T07:22:25Z |
Potential source of environmentally benign antifungal agents from Cinnamomum osmophloeum leaves against Phellinus noxius
|
Cheng S.-S.; Lin C.-Y.; Chung M.-J.; Chen Y.-J.; Chang S.-T.; SHANG-TZEN CHANG; Cheng S.-S.;Lin C.-Y.;Chung M.-J.;Chen Y.-J.;Chang S.-T. |
| 臺大學術典藏 |
2021-06-22T02:00:35Z |
Potential source of environmentally benign antifungal agents from Cinnamomum osmophloeum leaves against Phellinus noxius
|
Cheng, S.-S.;Lin, C.-Y.;Chung, M.-J.;Chen, Y.-J.;Chang, S.-T.; Cheng, S.-S.; Lin, C.-Y.; Chung, M.-J.; Chen, Y.-J.; Chang, S.-T.; SHANG-TZEN CHANG |
| 國立交通大學 |
2014-12-08T15:22:33Z |
Potential Source Regions Contributing to Seasonal Variations of Black Carbon Aerosols over Anantapur in Southeast India
|
Reddy, B. Suresh Kumar; Kumar, K. Raghavendra; Balakrishnaiah, G.; Gopal, K. Rama; Reddy, R. R.; Reddy, L. S. S.; Ahammed, Y. Nazeer; Narasimhulu, K.; Moorthy, K. Krishna; Babu, S. Suresh |
| 臺大學術典藏 |
2020-05-19T04:07:53Z |
Potential spatial accessibility of health care resources: An example of four counties and cities in northern Taiwan
|
Ching-Chen H.; Hsin-Chung L.; Ming-Chin Y.; YU-CHI TUNG |
| 臺大學術典藏 |
2020-05-20T04:46:50Z |
Potential spatial accessibility of health care resources: an example of four counties and cities in northern Taiwan
|
謝京辰; 廖興中; 楊銘欽; 董鈺琪; Ching-Chen Hsieh; Hsin-Chung Liao; MING-CHIN YANG; Yu-Chi Tung |
| 國立成功大學 |
2024-06 |
Potential stability of the Fokker-Planck equation
|
Lyu;Ming-Jiea;Tsai;Dong-Ho;Wu;Kuang-Yu;Wu;Kung-Chien |
| 國立成功大學 |
2024 |
Potential stability of the Fokker–Planck equation
|
Lyu;M, -J.;Tsai;D, -H.;Wu;K, -Y.;Wu;K, -C. |
| 臺大學術典藏 |
2014 |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou D.-L.; Chang C.-J.; Jeng Y.-M.; Lin Y.-J.; Lin Z.-Z.; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; CHIUN HSU; Cheng A.-L. |
| 國立臺灣大學 |
2014 |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou, Da-Liang; Chang, Chun-Jung; Jeng, Yung-Ming; Lin, Yi-Jang; Lin, Zhong-Zhe; Gandhi, Anita K.; Liao, Sheng-Chieh; Huang, Zi-Ming; Hsu, Chiun; Cheng, Ann-Lii; 鄭永銘; 張純榮; 林宗哲; 鄭安理; 許駿; 歐大諒 |
| 臺大學術典藏 |
2018-09-10T14:58:12Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou, D.-L. and Chang, C.-J. and Jeng, Y.-M. and Lin, Y.-J. and Lin, Z.-Z. and Gandhi, A.K. and Liao, S.-C. and Huang, Z.-M. and Hsu, C. and Cheng, A.-L.; Ou, Da-Liang;Chang, Chun-Jung;Jeng, Yung-Ming;Lin, Yi-Jang;Lin, Zhong-Zhe;Gandhi, Anita K.;Liao, Sheng-Chieh;Huang, Zi-Ming;Hsu, Chiun;Cheng, Ann-Lii; 鄭永銘;張純榮;林宗哲;鄭安理;許駿;歐大諒; YUNG-MING JENG; Ou, Da-Liang; Chang, Chun-Jung; Jeng, Yung-Ming; Lin, Yi-Jang; Lin, Zhong-Zhe; Gandhi, Anita K.; Liao, Sheng-Chieh; Huang, Zi-Ming; Hsu, Chiun; Cheng, Ann-Lii; �G�w�z |
| 臺大學術典藏 |
2020-03-06T08:25:06Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou D.-L.;Chang C.-J.;Yung-Ming Jeng;Lin Y.-J.;Lin Z.-Z.;Gandhi A.K.;Liao S.-C.;Huang Z.-M.;Hsu C.;Cheng A.-L.; Ou D.-L.; Chang C.-J.; YUNG-MING JENG; Lin Y.-J.; Lin Z.-Z.; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Hsu C.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-10T12:51:09Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou D.-L.; Chang C.-J.; Jeng Y.-M.; Lin Y.-J.; Lin Z.-Z.; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Chiun Hsu; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:42Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou D.-L.; Chang C.-J.; Jeng Y.-M.; Lin Y.-J.; ZHONG-ZHE LIN; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Hsu C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-31T06:42:25Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou D.-L.; Chang C.-J.; Jeng Y.-M.; Lin Y.-J.; Lin Z.-Z.; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Hsu C.; ANN-LII CHENG |
| 臺大學術典藏 |
2022-06-10T06:11:04Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou D.-L.; Chang C.-J.; Jeng Y.-M.; Lin Y.-J.; ZHONG-ZHE LIN; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Hsu C.; Cheng A.-L. |
| 國立臺灣大學 |
2013 |
Potential synergistic antitumor activity between sorafenib and lenalidomide in an orthotopic murine liver cancer model.
|
Chang, Chun-Jung; Ou, Da-Liang; Lin, Yi-Jang; Cheng, Ann-Lii; Hsu, Chiun; 張純榮; 鄭安理; 許駿; 歐大諒 |
| 臺大學術典藏 |
2021-05-24T13:07:51Z |
Potential syntrophic relationship between coral-associated Prosthecochloris and its companion sulfate-reducing bacterium unveiled by genomic analysis
|
Chen, Yu Hsiang; SHAN-HUA YANG; Tandon, Kshitij; Lu, Chih Ying; Chen, Hsing Ju; Shih, Chao Jen; Tang, Sen Lin |
| 臺大學術典藏 |
2021-07-26T10:04:12Z |
Potential syntrophic relationship between coral-associated Prosthecochloris and its companion sulfate-reducing bacterium unveiled by genomic analysis
|
Chen Y.-H;Yang S.-H;Tandon K;Lu C.-Y;Chen H.-J;Shih C.-J;Tang S.-L.; Chen Y.-H; Yang S.-H; Tandon K; Lu C.-Y; Chen H.-J; Shih C.-J; Tang S.-L.; SHAN-HUA YANG |
| 國家衛生研究院 |
2018-07-30 |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin, YF;Chen, L;Lin, SL;Yeh, YC;Huang, TM;Chou, YH;Chang, FC;Chen, YT;Yang, SY;Lai, TS;Wu, VC;Chu, TS;Wu, KD;(NSARF), the National Taiwan University Hospital Study Group on Acute Renal Failure;Group, Taiwan Primary Aldosteronism Investigation (TAIPAI) Study |
| 臺大學術典藏 |
2019-02-20T01:37:21Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin, Yu-Feng;Chen, Likwang;Lin, Shuei-Liong;Yu-Chang Yeh;Huang, Tao-Min;Yu-Hsiang Chou;Chang, Fan-Chi;Chen, Yi-Ting;Yang, Shao-Yu;Tai-Shuan Lai;Wu, Vin-Cent;Chu, Tzong-Shinn;Wu, Kwan-Dun; Lin, Yu-Feng; Chen, Likwang; Lin, Shuei-Liong; YU-CHANG YEH; Huang, Tao-Min; YU-HSIANG CHOU; Chang, Fan-Chi; Chen, Yi-Ting; Yang, Shao-Yu; TAI-SHUAN LAI; Wu, Vin-Cent; Chu, Tzong-Shinn; Wu, Kwan-Dun |
| 臺大學術典藏 |
2019-03-07T06:42:31Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin, Yu-Feng; Chen, Likwang; Lin, Shuei-Liong; YU-CHANG YEH; Huang, Tao-Min; YU-HSIANG CHOU; Chang, Fan-Chi; Chen, Yi-Ting; Yang, Shao-Yu; TAI-SHUAN LAI; Wu, Vin-Cent; Chu, Tzong-Shinn; Wu, Kwan-Dun; Lin, Yu-Feng;Chen, Likwang;Lin, Shuei-Liong;Yu-Chang Yeh;Huang, Tao-Min;Yu-Hsiang Chou;Chang, Fan-Chi;Chen, Yi-Ting;Yang, Shao-Yu;Tai-Shuan Lai;Wu, Vin-Cent;Chu, Tzong-Shinn;Wu, Kwan-Dun |
| 臺大學術典藏 |
2019-03-07T06:45:13Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin, Yu-Feng;Chen, Likwang;Lin, Shuei-Liong;Yu-Chang Yeh;Huang, Tao-Min;Yu-Hsiang Chou;Chang, Fan-Chi;Chen, Yi-Ting;Yang, Shao-Yu;Tai-Shuan Lai;Wu, Vin-Cent;Chu, Tzong-Shinn;Wu, Kwan-Dun; Lin, Yu-Feng; Chen, Likwang; Lin, Shuei-Liong; YU-CHANG YEH; Huang, Tao-Min; YU-HSIANG CHOU; Chang, Fan-Chi; Chen, Yi-Ting; Yang, Shao-Yu; TAI-SHUAN LAI; Wu, Vin-Cent; Chu, Tzong-Shinn; Wu, Kwan-Dun |
| 臺大學術典藏 |
2019-01 |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Wu, Kwan-Dun; TZONG-SHINN CHU; VIN-CENT WU; Yu-Feng Lin;Chen, Likwang;Shuei-Liong Lin;Yu-Chang Yeh;Huang, Tao-Min;Chou, Yu-Hsiang;Chang, Fan-Chi;Chen, Yi-Ting;Shao-Yu Yang;Tai-Shuan Lai;Vin-Cent Wu;Tzong-Shinn Chu;Wu, Kwan-Dun; YU-FENG LIN; Chen, Likwang; SHUEI-LIONG LIN; YU-CHANG YEH; Huang, Tao-Min; Chou, Yu-Hsiang; Chang, Fan-Chi; Chen, Yi-Ting; SHAO-YU YANG; TAI-SHUAN LAI |
| 臺大學術典藏 |
2020-05-26T03:25:54Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.;Chen L.;Lin S.-L.;Yeh Y.-C.;Huang T.-M.;Yu-Hsiang Chou;Chang F.-C.;Chen Y.-T.;Yang S.-Y.;Lai T.-S.;Wu V.-C.;Chu T.-S.;Wu K.-D.; Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; YU-HSIANG CHOU; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2020-09-28T07:04:26Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lai T.-S.; Chen Y.-T.; Yang S.-Y.; Chang F.-C.; Chou Y.-H.; Huang T.-M.; Yeh Y.-C.; Lin S.-L.; Chen L.; Lin Y.-F.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2020-12-24T05:52:20Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lai T.-S.; SHAO-YU YANG; Chen Y.-T.; Chang F.-C.; Huang T.-M.; Chou Y.-H.; Yeh Y.-C.; Lin S.-L.; Chen L.; Lin Y.-F.; Lin Y.-F.;Chen L.;Lin S.-L.;Yeh Y.-C.;Huang T.-M.;Chou Y.-H.;Chang F.-C.;Chen Y.-T.;Shao-Yu Yang;Lai T.-S.;Wu V.-C.;Chu T.-S.;Wu K.-D.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2020-12-24T07:20:00Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Wu K.-D.; Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; TAI-SHUAN LAI; Wu V.-C.; Chu T.-S. |
| 臺大學術典藏 |
2021-01-12T03:32:05Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
SHUEI-LIONG LIN; Chen L.; Lin Y.-F.; Lin Y.-F.;Chen L.;Shuei-Liong Lin;Yeh Y.-C.;Huang T.-M.;Chou Y.-H.;Chang F.-C.;Chen Y.-T.;Yang S.-Y.;Lai T.-S.;Wu V.-C.;Chu T.-S.;Wu K.-D.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2020-12-23T02:57:02Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.; Lin Y.-F.;Chen L.;Lin S.-L.;Yeh Y.-C.;Huang T.-M.;Chou Y.-H.;Chang F.-C.;Chen Y.-T.;Yang S.-Y.;Lai T.-S.;Vin-Cent Wu;Chu T.-S.;Wu K.-D.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; VIN-CENT WU; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-06-25T07:21:52Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
YU-FENG LIN; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-07-20T03:15:26Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; TZONG-SHINN CHU; Wu K.-D. |
| 臺大學術典藏 |
2021-08-23T03:43:54Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; FAN-CHI CHANG; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-08-23T23:47:20Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; YI-TING CHEN; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:53:36Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; VIN-CENT WU; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-08-24T02:10:08Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; TAO-MIN HUANG; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 國立臺灣大學 |
2015 |
Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma
|
Liu, Chien-Ming; Chiu, Kuo-Liang; Chen, Tzu-Sheng; Chang, Shang-Miao; Yang, Shu-Yun; Chen, Li-Hsiou; Ni, Yung-Lun; Sher, Yuh-Pyng; Yu, Sung-Liang; Ma, Wen-Lung; 俞松良 |
| 國家衛生研究院 |
2019-02-15 |
Potential therapeutic effect of curcumin, a natural mTOR inhibitor, in tuberous sclerosis complex
|
Kuo, CJ;Huang, CC;Chou, SY;Lo, YC;Kao, TJ;Huang, NK;Lin, C;Lin, HC;Lin, HC;Lee, YC |
| 臺大學術典藏 |
2013 |
Potential therapeutic role of hispidulin in gastric cancer through induction of apoptosis via NAG-1 signaling
|
Yu, C.Y. and Su, K.-Y. and Lee, P.-L. and Jhan, J.-Y. and Tsao, P.-H. and Chan, D.-C. and Chen, Y.-L.S.; KANG-YI SU |
| 臺大學術典藏 |
2020-06-30T08:10:08Z |
Potential therapeutic role of Z-isochaihulactone in lung cancer through induction of apoptosis via notch signaling
|
Ou J.-P.;Lin H.-Y.;Kang-Yi Su;Yu S.-L.;Tseng I.-H.;Chen C.-J.;Hsu H.-C.;Chan D.-C.;Sophia Chen Y.-L.; Ou J.-P.; Lin H.-Y.; KANG-YI SU; Yu S.-L.; Tseng I.-H.; Chen C.-J.; Hsu H.-C.; Chan D.-C.; Sophia Chen Y.-L. |
| 中國醫藥大學 |
2013-05-31 |
Potential Therapeutic SERPINB Genes and RCL-derived Peptides for Inhibition of Malignancy of Lung Cancer Cells
|
;(Hui-Chin Wen);(Wei-Guang Liang);(Sheng-Chieh Lin);(Hsiao-Wei Yuan);(Cheng-Wen Wu);(Wun-Shaing Wayne Chang)* |
| 臺大學術典藏 |
2021-11-02T05:46:27Z |
Potential therapeutics using tumor-secreted lactate in nonsmall cell lung cancer
|
Liao, Zi-Xian; Kempson, Ivan M; Hsieh, Chia-Chen; Tseng, S-Ja; PAN-CHYR YANG |
